Prolastin® (Alpha1-Antitrypsin Inhibitor [Human])
Alpha1-antitrypsin deficiency, also known as Alpha-1, is an inherited disorder that causes
significant reduction in the naturally occurring protein alpha1 antitrypsin (AAT). Scientists
also call this protein alpha-1 proteinase inhibitor (A1 PI) because it inhibits not only
trypsin but also other enzymes called proteinases. A doctor or healthcare provider
prescribes an alpha-1 proteinase inhibitor.
Please note: Country-specific regulatory requirements limit the information we can provide about our products. In addition,
approved indications (uses), product labels, and packaging for a prescription drug may differ between
countries. Please refer to the prescribing information provided for your country of residence.
Prolastin® (Alpha1- Proteinase Inhibitor [Human]) reaches patients around the world, including in:
Important Safety Information
Thrombate III therapy has demonstrated a low occurrence of side effects. In clinical studies with Thrombate III, the most common side effects were dizziness, chest tightness, nausea, and a foul taste in the mouth. As with all plasma-derived therapeutics, the potential to transmit infectious agents, such as viruses, cannot be totally eliminated. Individuals who receive infusions of blood or blood plasma may develop signs and/or symptoms of some viral infections, particularly hepatitis C.
Please see full Prescribing Information for Thrombate III.
|